48,830
edits
Line 93: | Line 93: | ||
*#[[Uterine cervix|Cervical cancer]] and precursors ([[LSIL]], [[HSIL]]). | *#[[Uterine cervix|Cervical cancer]] and precursors ([[LSIL]], [[HSIL]]). | ||
*#Anal cancer and precursors ([[Anus#Anal_intraepithelial_neoplasia|AIN]]).<ref name=pmid21616117>{{Cite journal | last1 = Borget | first1 = I. | last2 = Abramowitz | first2 = L. | last3 = Mathevet | first3 = P. | title = Economic burden of HPV-related cancers in France. | journal = Vaccine | volume = 29 | issue = 32 | pages = 5245-9 | month = Jul | year = 2011 | doi = 10.1016/j.vaccine.2011.05.018 | PMID = 21616117 }}</ref> | *#Anal cancer and precursors ([[Anus#Anal_intraepithelial_neoplasia|AIN]]).<ref name=pmid21616117>{{Cite journal | last1 = Borget | first1 = I. | last2 = Abramowitz | first2 = L. | last3 = Mathevet | first3 = P. | title = Economic burden of HPV-related cancers in France. | journal = Vaccine | volume = 29 | issue = 32 | pages = 5245-9 | month = Jul | year = 2011 | doi = 10.1016/j.vaccine.2011.05.018 | PMID = 21616117 }}</ref> | ||
*#[[Vulva|Vulvar cancer | *#[[Vulva|Vulvar cancer]].<ref name=pmid21616117/> | ||
*#[[Vagina|Vaginal cancer]].<ref name=pmid21616117/> | *#[[Vagina|Vaginal cancer]].<ref name=pmid21616117/> | ||
*#[[Penis|Penile cancer]].<ref name=pmid21616117/> | *#[[Penis|Penile cancer]].<ref name=pmid21616117/> |
edits